HLA and cancer: implications for cancer immunotherapy and vaccination.
about
The human Major Histocompatibility Complex as a paradigm in genomics researchNon-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis.Human leukocyte antigens and cancer: is it in our genes?The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma.Role of gene methylation in antitumor immune response: implication for tumor progression.Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.Human antigen-presenting cell/tumour cell hybrids stimulate strong allogeneic responses and present tumour-associated antigens to cytotoxic T cells in vitro.Contribution of susceptibility locus at HLA class I region and environmental factors to occurrence of nasopharyngeal cancer in Northeast India.HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines.
P2860
Q24596895-8F94586F-AAEC-49DF-99C2-F9B2D042C98CQ30315505-FEE0C498-8664-4EBE-8D6B-EA65C01F17CEQ33695538-10FF28E8-D7B9-4721-88AF-7698E07BC5EDQ33845782-34EB22CE-8E66-460A-8758-C4DC3BD96562Q37132658-6251E676-E47F-4379-B0DB-B58B6B1A3CE5Q40272196-7082DBB8-BB98-4DBC-AE71-ED77CA145B0CQ40912686-D822D0B3-1B48-4513-925F-9AAAFDA7A019Q42176818-8462165E-6F54-440B-A472-07074EEC77B5Q47727042-04D115DE-142F-4C78-A9ED-F9CE2774BD41
P2860
HLA and cancer: implications for cancer immunotherapy and vaccination.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
HLA and cancer: implications for cancer immunotherapy and vaccination.
@en
type
label
HLA and cancer: implications for cancer immunotherapy and vaccination.
@en
prefLabel
HLA and cancer: implications for cancer immunotherapy and vaccination.
@en
P2860
P1476
HLA and cancer: implications for cancer immunotherapy and vaccination.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2370.1997.TB00025.X
P577
1997-08-01T00:00:00Z